- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Poll
Article
POLL: Do You Diagnose and Treat Psoriasis Through Telehealth Appointments?
Author(s):
Key Takeaways
- Telehealth usage in hospitals increased significantly from 2010 to 2017, with further growth expected post-pandemic.
- The COVID-19 pandemic accelerated telehealth integration, enhancing access to healthcare services.
Click here to answer this week’s poll.
Do you diagnose and treat psoriasis through telehealth appointments?
The use of telehealth in hospitals grew from 35% in 2010 to 76% in 20171, and since the COVID-19 pandemic, that number has likely increased. Do you diagnose and/or treat psoriasis through telehealth appointments?
Reference
- Fact Sheet: Telehealth. American Hospital Association. Accessed August 24, 2023. https://www.aha.org/factsheet/telehealth#:~:text=Telehealth%20connects%20patients%20to%20vital,place%2C%20at%20the%20right%20time
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Safety Considerations for IL-17 Inhibitors
Selecting and Dosing IL-17 Inhibitors in Psoriasis
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
Clinical Attributes of IL-17 Inhibitors in Psoriasis
Mechanism of Action Differences Among IL-17 Inhibitors
The Role of IL-17 in Psoriasis Pathogenesis
New Research Confirms Effective Therapy for Nail Psoriasis
New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
Addressing Disparities in Inflammatory Skin Diseases in Darker Skin Tones
Related Content
